Positron emission tomography scanning in the assessment of patients with lymphoma
- 21 July 2004
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 34 (7), 388-397
- https://doi.org/10.1111/j.1445-5994.2004.00614.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphomaAmerican Journal Of Medicine, 2002
- Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphomaCancer, 2002
- The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatmentSeminars in Nuclear Medicine, 2001
- Current status of positron emission tomography in oncologyInternal Medicine Journal, 2001
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Comparisons of Predictive Values of Binary Medical Diagnostic Tests for Paired DesignsBiometrics, 2000
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1998
- Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.Journal of Clinical Oncology, 1997
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Residual mass in lymphoma may not be residual disease.Journal of Clinical Oncology, 1988